FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

David Fiellin

Research Profile

Disorders

Chemicals & Drugs

Procedures

Geographic Areas

United States

Concepts & Ideas

Living Beings

Veterans

Co-author Network

Publications

TOP 3
Brent A Moore; Richard S Schottenfeld; Declan T Barry; Christopher J Cutter; Tera Fazzino; David A Fiellin; Samuel A Ball
The Recovery Line: A pilot trial of automated, telephone-based treatment for continued drug use in methadone maintenance.
Declan T Barry; Mark Beitel; Christopher J Cutter; Brent A Moore; Jonathan D Savant; Richard S Schottenfeld; David A Fiellin
Pain and Associated Substance Use among Opioid Dependent Individuals Seeking Office-Based Treatment with Buprenorphine-Naloxone: A Needs Assessment Study.
David A Fiellin; Amy C Justice; Stephen A Maisto; Kathleen A McGinnis; Kendall Bryant
Measuring alcohol consumption using Timeline Followback in non-treatment-seeking medical clinic patients with and without HIV infection: 7-, 14-, or 30-day recall.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of David Fiellin (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Brent A Moore; Richard S Schottenfeld; Declan T Barry; Christopher J Cutter; Tera Fazzino; David A Fiellin; Samuel A Ball
The Recovery Line: A pilot trial of automated, telephone-based treatment for continued drug use in methadone maintenance.
Journal of substance abuse treatment 2013;45(1):63-9.
2013: Declan T Barry; Mark Beitel; Christopher J Cutter; Brent A Moore; Jonathan D Savant; Richard S Schottenfeld; David A Fiellin
Pain and Associated Substance Use among Opioid Dependent Individuals Seeking Office-Based Treatment with Buprenorphine-Naloxone: A Needs Assessment Study.
The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions 2013;22(3):212-7.
2013: David A Fiellin; Amy C Justice; Stephen A Maisto; Kathleen A McGinnis; Kendall Bryant
Measuring alcohol consumption using Timeline Followback in non-treatment-seeking medical clinic patients with and without HIV infection: 7-, 14-, or 30-day recall.
Journal of studies on alcohol and drugs 2013;74(3):500-4.
2013: Jeanette M Tetrault; Jennifer Chiarella; An T Dinh; Michael J Kozal; Lynn E Sullivan; David A Fiellin
Association between risk behaviors and antiretroviral resistance in HIV-infected patients receiving opioid agonist treatment.
Journal of addiction medicine 2013;7(2):102-7.
2013: Joseph L Goulet; Robert D Kerns; Stephen Maisto; Cynthia Brandt; Stephen Crystal; David A Fiellin; Cynthia Gibert; Adam J Gordon; Amy C Justice
Agreement between electronic medical record-based and self-administered pain numeric rating scale: clinical and research implications.
Medical care 2013;51(3):245-50.
2013: Kathleen A McGinnis; Richard Saitz; Kendall J Bryant; Amy C Justice; Kevin L Kraemer; David A Fiellin
Comparing alcohol screening measures among HIV-infected and -uninfected men.
Alcoholism, clinical and experimental research 2013;37(3):435-42.
2013: Stephen R Holt; Coeurlida Louis-Ashby; Jorge Ramos; Felix Cabrera; An Dinh; David A Fiellin; Michael Harma; Jeanette M Tetrault
Physician detection of unhealthy substance use on inpatient teaching and hospitalist medical services.
The American journal of drug and alcohol abuse 2013;39(2):121-9.
2013: Lynn E Fiellin; William C Becker; David A Fiellin; Jeanette M Tetrault; Rani A Hoff
Previous use of alcohol, cigarettes, and marijuana and subsequent abuse of prescription opioids in young adults.
The Journal of adolescent health : official publication of the Society for Adolescent Medicine 2013;52(2):158-63.
2013: David A Fiellin; Brent A Moore; Patrick G O'Connor; Declan T Barry; Christopher J Cutter; Lynn E Sullivan; Richard S Schottenfeld
A randomized trial of cognitive behavioral therapy in primary care-based buprenorphine.
The American journal of medicine 2013;126(1):74.e11-7.
2013: E Jennifer Edelman; David A Fiellin
Moving HIV pre-exposure prophylaxis into clinical settings: lessons from buprenorphine.
American journal of preventive medicine 2013;44(1 Suppl 2):S86-90.
2013: Michael E Ohl; Eli Perencevich; David Rimland; Melissa Skanderson; Karen Wang; Kathleen Akgun; David A Fiellin; Nancy Kim; D Keith McInnes; Amy Justice
Antiretroviral adherence among rural compared to urban veterans with HIV infection in the United States.
AIDS and behavior 2013;17(1):174-80.
2013: E Jennifer Edelman; William C Becker; Jennifer Brennan Braden; Julie R Gaither; Adam J Gordon; Kirsha Gordon; Joseph L Goulet; Amy C Justice; Robert D Kerns; Melissa Skanderson; David A Fiellin
Receipt of opioid analgesics by HIV-infected and uninfected patients.
Journal of general internal medicine 2013;28(1):82-90.
2013: Karen H Wang; William C Becker; David A Fiellin
Prevalence and correlates for nonmedical use of prescription opioids among urban and rural residents.
Drug and alcohol dependence 2013;127(1-3):156-62.
2013: Jonathan D Savant; Richard S Schottenfeld; Michelle T Joy; Declan T Barry; Christopher J Cutter; An Dinh; David A Fiellin
Prevalence of mood and substance use disorders among patients seeking primary care office-based buprenorphine/naloxone treatment.
Drug and alcohol dependence 2013;127(1-3):243-7.
2012: Declan T Barry; Mark Beitel; Christopher J Cutter; Brent A Moore; Jonathan D Savant; Richard S Schottenfeld; David A Fiellin
Use of conventional, complementary, and alternative treatments for pain among individuals seeking primary care treatment with buprenorphine-naloxone.
Journal of addiction medicine 2012;6(4):274-9.
2012: Michael V Pantalon; James Dziura; David A Fiellin; Fang-Yong Li; Steve Martino; Patrick G O'Connor; Patricia H Owens; Gail D'Onofrio
Development of a scale to measure practitioner adherence to a brief intervention in the emergency department.
Journal of substance abuse treatment 2012;43(4):382-8.
2012: Jeanette M Tetrault; Declan T Barry; David A Fiellin; Brent A Moore; Patrick G O'Connor; Richard S Schottenfeld; Lynn E Fiellin
Brief versus extended counseling along with buprenorphine/naloxone for HIV-infected opioid dependent patients.
Journal of substance abuse treatment 2012;43(4):433-9.
2012: E Jennifer Edelman; David A Fiellin; An Dinh; Gail D'Onofrio; Bonnie Lurie; Radu Radulescu; Jeanette M Tetrault; Lynn E Fiellin
Combining rapid HIV testing and a brief alcohol intervention in young unhealthy drinkers in the emergency department: a pilot study.
The American journal of drug and alcohol abuse 2012;38(6):539-43.
2012: Philip Todd Korthuis; Kathleen A McGinnis; David Rimland; Maria C Rodriguez-Barradas; Melissa Skanderson; Steven M Asch; Kendall Bryant; Stephen Crystal; Donna Almario Doebler; David A Fiellin; Lynn E Fiellin; Cynthia L Gibert; Matthew Bidwell Goetz; Adam J Gordon; Amy C Justice; Kevin L Kraemer
Unhealthy alcohol and illicit drug use are associated with decreased quality of HIV care.
Journal of acquired immune deficiency syndromes (1999) 2012;61(2):171-8.
2012: Brent A Moore; Patrick G Oʼconnor; Richard S Schottenfeld; Lynn E Sullivan; Declan T Barry; Christopher J Cutter; David A Fiellin
Counseling and directly observed medication for primary care buprenorphine maintenance: a pilot study.
Journal of addiction medicine 2012;6(3):205-11.
2012: William C Becker; David A Fiellin
Federal plan for prescriber education on opioids misses opportunities.
Annals of internal medicine 2012;157(3):205-6.
2012: Gail D'Onofrio; David A Fiellin; Patricia H Owens; Michael V Pantalon; Steven L Bernstein; Susan H Busch; Marek C Chawarski; Linda Degutis; Patrick G O'Connor
A brief intervention reduces hazardous and harmful drinking in emergency department patients.
Annals of emergency medicine 2012;60(2):181-92.
2012: E Jennifer Edelman; David A Fiellin; Brent A Moore; Richard S Schottenfeld; An T Dinh; Lynn E Sullivan
Human immunodeficiency virus testing practices among buprenorphine-prescribing physicians.
Journal of addiction medicine 2012;6(2):159-65.
2012: Bruce R Schackman; Jared A Leff; Brent A Moore; Daniel Polsky; David A Fiellin
Cost-effectiveness of long-term outpatient buprenorphine-naloxone treatment for opioid dependence in primary care.
Journal of general internal medicine 2012;27(6):669-76.
2012: Amy C Justice; Lew Kuller; Kris Ann K Kwiterovic Oursler; Maria C Rodriguez-Barradas; Janet P Tate; Russ Tracy; Gary J Vanasse; Kendall Bryant; Adeel A Butt; Steven G Deeks; David A Fiellin; Matthew S Freiberg; Cynthia Gibert; Matthew Bidwell Goetz
Does an index composed of clinical data reflect effects of inflammation, coagulation, and monocyte activation on mortality among those aging with HIV?
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2012;54(7):984-94.
2012: Stephen R Holt; Coeurlida Louis-Ashby; Jorge Ramos; Jeanette M Tetrault; Felix Cabrera; An Dinh; Michael A Harma; David A Fiellin
Prevalence of unhealthy substance use on teaching and hospitalist medical services: implications for education.
The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions 2012;21(2):111-9.
2012: Jeanette M Tetrault; Kendall Bryant; David A Fiellin; Joseph L Goulet; Amy C Justice; Kathleen A McGinnis; Lynn E Sullivan; Janet P Tate
Hepatic safety and antiretroviral effectiveness in HIV-infected patients receiving naltrexone.
Alcoholism, clinical and experimental research 2012;36(2):318-24.
2012: Jeanette M Tetrault; David A Fiellin
Current and potential pharmacological treatment options for maintenance therapy in opioid-dependent individuals.
Drugs 2012;72(2):217-28.
2012: Sheryl A Ryan; Jeanette M Tetrault; Stephen F Thung; Peggy Auinger; Steven L Bernstein; David A Fiellin; Michael L Green; Shara Martel; Steve Martino; Patrick G O'Connor; Michael V Pantalon; Gail D'Onofrio
Screening, brief intervention, and referral to treatment (SBIRT) for alcohol and other drug use among adolescents: evaluation of a pediatric residency curriculum.
Substance abuse : official publication of the Association for Medical Education and Research in Substance Abuse 2012;33(3):251-60.
2012: Jeanette M Tetrault; Stephen F Thung; Steven L Bernstein; Linda Degutis; David A Fiellin; Michael L Green; Shara Martel; Steve Martino; Patrick G O'Connor; Michael V Pantalon; Sheryl A Ryan; Gail D'Onofrio
Developing and implementing a multispecialty graduate medical education curriculum on Screening, Brief Intervention, and Referral to Treatment (SBIRT).
Substance abuse : official publication of the Association for Medical Education and Research in Substance Abuse 2012;33(2):168-81.
2011: Roger D Weiss; Elinore F McCance-Katz; Jennifer Potter; Scott E Provost; Jeffrey Selzer; Eugene C Somoza; Susan C Sonne; Marilyn Byrne; Hilary Smith Connery; William Dickinson; David A Fiellin; John Gardin; Marc N Gourevitch; Margaret L Griffin; Deborah L Haller; Albert L Hasson; Zhen Huang; Petra Jacobs; Andrzej S Kosinski; Robert Lindblad; Walter Ling
Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence: a 2-phase randomized controlled trial.
Archives of general psychiatry 2011;68(12):1238-46.
2011: Oni J Blackstock; Karen H Wang; David A Fiellin
State variation in AIDS drug assistance program prescription drug coverage for modifiable cardiovascular risk factors.
Journal of general internal medicine 2011;26(12):1426-33.
2011: Emily A Wang; Kendall Bryant; David A Fiellin; Cynthia L Gibert; Joseph L Goulet; Amy C Justice; David A Leaf; Kristin Mattocks; Kathleen A McGinnis; Lynn E Sullivan; Nicholas Vogenthaler
Food insecurity is associated with poor virologic response among HIV-infected patients receiving antiretroviral medications.
Journal of general internal medicine 2011;26(9):1012-8.
2011: Lynn E Sullivan; Jeanette M Tetrault; Barbara J Turner; R Scott Braithwaite; David A Fiellin
A meta-analysis of the efficacy of nonphysician brief interventions for unhealthy alcohol use: implications for the patient-centered medical home.
The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions 2011;20(4):343-56.
2011: William C Becker; Daniel G Tobin; David A Fiellin
Nonmedical use of opioid analgesics obtained directly from physicians: prevalence and correlates.
Archives of internal medicine 2011;171(11):1034-6.
2011: Onur Baser; Mady Chalk; David A Fiellin; David Gastfriend
Cost and utilization outcomes of opioid-dependence treatments.
The American journal of managed care 2011;17 Suppl 8():S235-48.
2011: Declan T Barry; Joseph L Goulet; Robert K Kerns; William C Becker; Adam J Gordon; Amy C Justice; David A Fiellin
Nonmedical use of prescription opioids and pain in veterans with and without HIV.
Pain 2011;152(5):1133-8.
2011: Paula J Lum; Sherri Little; Michael Botsko; David Hersh; Robert E Thawley; James E Egan; Jennifer Mitty; Joshua Boverman; David A Fiellin
Opioid-prescribing practices and provider confidence recognizing opioid analgesic abuse in HIV primary care settings.
Journal of acquired immune deficiency syndromes (1999) 2011;56 Suppl 1():S91-7.
2011: Philip Todd Korthuis; David A Fiellin; Rongwei Fu; Paula J Lum; Frederick L. Altice; Nancy Sohler; Mary J Tozzi; Steven M Asch; Michael Botsko; Margaret Fishl; Timothy P Flanigan; Joshua Boverman; Dennis McCarty
Improving adherence to HIV quality of care indicators in persons with opioid dependence: the role of buprenorphine.
Journal of acquired immune deficiency syndromes (1999) 2011;56 Suppl 1():S83-90.
2011: Bruce R Schackman; Jared A Leff; Michael Botsko; David A Fiellin; Fredrick L Altice; Philip Todd Korthuis; Nancy Sohler; Linda Weiss; James E Egan; Julie Netherland; Jonathan Gass; Ruth Finkelstein
The cost of integrated HIV care and buprenorphine/naloxone treatment: results of a cross-site evaluation.
Journal of acquired immune deficiency syndromes (1999) 2011;56 Suppl 1():S76-82.
2011: Linda Weiss; James E Egan; Michael Botsko; Julie Netherland; David A Fiellin; Ruth Finkelstein
The BHIVES collaborative: organization and evaluation of a multisite demonstration of integrated buprenorphine/naloxone and HIV treatment.
Journal of acquired immune deficiency syndromes (1999) 2011;56 Suppl 1():S7-13.
2011: Linda Weiss; Julie Netherland; James E Egan; Timothy P Flanigan; David A Fiellin; Ruth Finkelstein; Frederick L. Altice
Integration of buprenorphine/naloxone treatment into HIV clinical care: lessons from the BHIVES collaborative.
Journal of acquired immune deficiency syndromes (1999) 2011;56 Suppl 1():S68-75.
2011: Pamela Vergara-Rodriguez; Mary Jo Tozzi; Michael Botsko; Vijay Nandi; Frederick L. Altice; James E Egan; Patrick G O'Connor; Lynn E Sullivan; David A Fiellin
Hepatic safety and lack of antiretroviral interactions with buprenorphine/naloxone in HIV-infected opioid-dependent patients.
Journal of acquired immune deficiency syndromes (1999) 2011;56 Suppl 1():S62-7.
2011: Lynn E Sullivan; Michael Botsko; Chinazo O Cunningham; Patrick G O'Connor; David Hersh; Jennifer Mitty; Paula J Lum; Richard S Schottenfeld; David A Fiellin
The impact of cocaine use on outcomes in HIV-infected patients receiving buprenorphine/naloxone.
Journal of acquired immune deficiency syndromes (1999) 2011;56 Suppl 1():S54-61.
2011: Philip Todd Korthuis; Mary Jo Tozzi; Vijay Nandi; David A Fiellin; Linda Weiss; James E Egan; Michael Botsko; Angela Acosta; Marc N Gourevitch; David Hersh; JEFFREY HSU; Joshua Boverman; Frederick L. Altice
Improved quality of life for opioid-dependent patients receiving buprenorphine treatment in HIV clinics.
Journal of acquired immune deficiency syndromes (1999) 2011;56 Suppl 1():S39-45.
2011: David A Fiellin; Linda Weiss; Michael Botsko; James E Egan; Frederick L. Altice; Lauri B Bazerman; Amina Chaudhry; Chinazo O Cunningham; Marc N Gourevitch; Paula J Lum; Lynn E Sullivan; Richard S Schottenfeld; Patrick G O'Connor
Drug treatment outcomes among HIV-infected opioid-dependent patients receiving buprenorphine/naloxone.
Journal of acquired immune deficiency syndromes (1999) 2011;56 Suppl 1():S33-8.
2011: Frederick L. Altice; R Douglas Bruce; Gregory M Lucas; Paula J Lum; Philip Todd Korthuis; Timothy P Flanigan; Chinazo O Cunningham; Lynn E Sullivan; Pamela Vergara-Rodriguez; David A Fiellin; Adan Cajina; Michael Botsko; Vijay Nandi; Marc N Gourevitch; Ruth Finkelstein
HIV treatment outcomes among HIV-infected, opioid-dependent patients receiving buprenorphine/naloxone treatment within HIV clinical care settings: results from a multisite study.
Journal of acquired immune deficiency syndromes (1999) 2011;56 Suppl 1():S22-32.
2011: Amina A Chaudhry; Michael Botsko; Linda Weiss; James E Egan; Jennifer Mitty; Barbara Estrada; Gregory M Lucas; Tanita Woodson; Timothy P Flanigan; David A Fiellin
Participant characteristics and HIV risk behaviors among individuals entering integrated buprenorphine/naloxone and HIV care.
Journal of acquired immune deficiency syndromes (1999) 2011;56 Suppl 1():S14-21.
2011: Jeanette M Tetrault; David A Fiellin
Adding buprenorphine implants to counselling reduces opioid use over 6 months in opioid-dependent adults.
Evidence-based mental health 2011;14(1):30.
2010: Lynn E Sullivan; David A Fiellin
The case for routine HIV screening and impact of managed care.
The American journal of managed care 2010;16(13 Suppl):S345-51.
2010: Declan T Barry; Kevin S Irwin; Emlyn S Jones; William C Becker; Jeanette M Tetrault; Lynn E Sullivan; Helena Hansen; Patrick G O'Connor; Richard S Schottenfeld; David A Fiellin
Opioids, chronic pain, and addiction in primary care.
The journal of pain : official journal of the American Pain Society 2010;11(12):1442-50.
2010: Jeanette M Tetrault; David A Fiellin; Linda M Niccolai; Lynn E Sullivan
Substance use in patients with sexually transmitted infections: results from a national U.S. survey.
The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions 2010;19(6):504-9.
2010: James E Egan; Paul Casadonte; Tracy Gartenmann; Judith Martin; Elinore F McCance-Katz; Julie Netherland; John A Renner; Linda Weiss; Andrew J Saxon; David A Fiellin
The Physician Clinical Support System-Buprenorphine (PCSS-B): a novel project to expand/improve buprenorphine treatment.
Journal of general internal medicine 2010;25(9):936-41.
2010: Traci C Green; Trace Kershaw; Haiqun Lin; Robert Heimer; Joseph L Goulet; Kevin L Kraemer; Adam J Gordon; Steve A Maisto; Nancy L Day; Kendall Bryant; David A Fiellin; Amy C Justice
Patterns of drug use and abuse among aging adults with and without HIV: a latent class analysis of a US Veteran cohort.
Drug and alcohol dependence 2010;110(3):208-20.
2010: R Scott Braithwaite; David A Fiellin; Kimberly Nucifora; Kendall Bryant; Mark Roberts; Nancy Kim; Amy C Justice
Evaluating interventions to improve antiretroviral adherence: how much of an effect is required for favorable value?
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2010;13(5):535-42.
2010: William C Becker; David A Fiellin; Robert D Kerns
Opioid doses and increased risk for overdose.
Annals of internal medicine 2010;153(1):59; author reply 59-60.
2010: Emily A Wang; Brent A Moore; Lynn E Sullivan; David A Fiellin
Effect of incarceration history on outcomes of primary care office-based buprenorphine/naloxone.
Journal of general internal medicine 2010;25(7):670-4.
2010: Gregory M Lucas; Amina Chaudhry; JEFFREY HSU; Tanita Woodson; Bryan Lau; Yngvild Olsen; Jeanne C Keruly; David A Fiellin; Ruth Finkelstein; PATRICIA CROVO; Katie Cook; Richard D Moore
Clinic-based treatment of opioid-dependent HIV-infected patients versus referral to an opioid treatment program: A randomized trial.
Annals of internal medicine 2010;152(11):704-11.
2010: Erik W Gunderson; Xin-Qun Wang; David A Fiellin; Benjamin Bryan; Frances R Levin
Unobserved versus observed office buprenorphine/naloxone induction: a pilot randomized clinical trial.
Addictive behaviors 2010;35(5):537-40.
2010: Kristen Sueoka; Joseph L Goulet; David A Fiellin; David Rimland; Adeel A Butt; Cynthia Gibert; Maria C Rodriguez-Barradas; Kendall Bryant; Stephen Crystal; Amy C Justice
Depression symptoms and treatment among HIV infected and uninfected veterans.
AIDS and behavior 2010;14(2):272-9.
2010: Robert L Cook; Kathleen A McGinnis; Jeffrey H Samet; David A Fiellin; Maria C Rodriguez-Barradas; Maria C Rodriquez-Barradas; Kevin L Kraemer; Cynthia L Gibert; R Scott Braithwaite; Joseph L Goulet; Kristin Mattocks; Stephen Crystal; Adam J Gordon; Kris Ann K Kwiterovic Oursler; Amy C Justice
Erectile dysfunction drug receipt, risky sexual behavior and sexually transmitted diseases in HIV-infected and HIV-uninfected men.
Journal of general internal medicine 2010;25(2):115-21.
2010: Lynn E Sullivan; Brent A Moore; Patrick G O'Connor; Declan T Barry; Marek C Chawarski; Richard S Schottenfeld; David A Fiellin
The association between cocaine use and treatment outcomes in patients receiving office-based buprenorphine/naloxone for the treatment of opioid dependence.
The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions 2010;19(1):53-8.
2009: R Scott Braithwaite; David A Fiellin; Amy C Justice
The payoff time: a flexible framework to help clinicians decide when patients with comorbid disease are not likely to benefit from practice guidelines.
Medical care 2009;47(6):610-7.
2009: William C Becker; David A Fiellin; Rollin M Gallagher; Kelly S Barth; Jennifer T Ross; David W Oslin
The association between chronic pain and prescription drug abuse in Veterans.
Pain medicine (Malden, Mass.) 2009;10(3):531-6.
2009: Julie Netherland; Michael Botsko; James E Egan; Andrew J Saxon; Chinazo O Cunningham; Ruth Finkelstein; Mark N Gourevitch; John A Renner; Nancy Sohler; Lynn E Sullivan; Linda Weiss; David A Fiellin
Factors affecting willingness to provide buprenorphine treatment.
Journal of substance abuse treatment 2009;36(3):244-51.
2009: Declan T Barry; Kevin S Irwin; Emlyn S Jones; William C Becker; Jeanette M Tetrault; Lynn E Sullivan; Helena Hansen; Patrick G O'Connor; Richard S Schottenfeld; David A Fiellin
Integrating buprenorphine treatment into office-based practice: a qualitative study.
Journal of general internal medicine 2009;24(2):218-25.
2009: Emlyn S Jones; Brent A Moore; Jody L Sindelar; Patrick G O'Connor; Richard S Schottenfeld; David A Fiellin
Cost analysis of clinic and office-based treatment of opioid dependence: results with methadone and buprenorphine in clinically stable patients.
Drug and alcohol dependence 2009;99(1-3):132-40.
2008: Adam J Gordon; David A Fiellin; Peter D Friedmann; Marc N Gourevitch; Kevin L Kraemer; Julia H Arnsten; Richard Saitz
Update in addiction medicine for the primary care clinician.
Journal of general internal medicine 2008;23(12):2112-6.
2008: David A Fiellin
Treatment of adolescent opioid dependence: no quick fix.
JAMA : the journal of the American Medical Association 2008;300(17):2057-9.
2008: Lynn E Sullivan; Brent A Moore; Marek C Chawarski; Michael V Pantalon; Declan Barry; Patrick G O'Connor; Richard S Schottenfeld; David A Fiellin
Buprenorphine/naloxone treatment in primary care is associated with decreased human immunodeficiency virus risk behaviors.
Journal of substance abuse treatment 2008;35(1):87-92.
2008: Gail D'Onofrio; Michael V Pantalon; Linda Degutis; David A Fiellin; Susan H Busch; Marek C Chawarski; Patricia H Owens; Patrick G O'Connor
Brief intervention for hazardous and harmful drinkers in the emergency department.
Annals of emergency medicine 2008;51(6):742-750.e2.
2008: Lynn E Sullivan; David A Fiellin
Narrative review: buprenorphine for opioid-dependent patients in office practice.
Annals of internal medicine 2008;148(9):662-70.
2008: William C Becker; David A Fiellin; Joseph O Merrill; Beryl Schulman; Ruth Finkelstein; Yngvild Olsen; Susan H Busch
Opioid use disorder in the United States: insurance status and treatment access.
Drug and alcohol dependence 2008;94(1-3):207-13.
2008: William C Becker; Lynn E Sullivan; Jeanette M Tetrault; Rani A Desai; David A Fiellin
Non-medical use, abuse and dependence on prescription opioids among U.S. adults: psychiatric, medical and substance use correlates.
Drug and alcohol dependence 2008;94(1-3):38-47.
2008: Jeffrey Levine; Karen E Brown; Marek Chawarski; David A Fiellin; William D White; William H Sledge
Major depression and recent physical or sexual abuse increase readmissions among high-utilising primary care patients.
Mental health in family medicine 2008;5(1):23-8.
2008: David A Fiellin; Brent A Moore; Lynn E Sullivan; William C Becker; Michael V Pantalon; Marek C Chawarski; Declan T Barry; Patrick G O'Connor; Richard S Schottenfeld
Long-term treatment with buprenorphine/naloxone in primary care: results at 2-5 years.
The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions 2008;17(2):116-20.
2008: Jeanette M Tetrault; Rani A Desai; William C Becker; David A Fiellin; John Concato; Lynn E Sullivan
Gender and non-medical use of prescription opioids: results from a national US survey.
Addiction (Abingdon, England) 2008;103(2):258-68.
2008: Erik W Gunderson; David A Fiellin
Office-based maintenance treatment of opioid dependence: how does it compare with traditional approaches?
CNS drugs 2008;22(2):99-111.
2007: Marek C Chawarski; David A Fiellin; Patrick G O'Connor; Mathew Bernard; Richard S Schottenfeld
Utility of sweat patch testing for drug use monitoring in outpatient treatment for opiate dependence.
Journal of substance abuse treatment 2007;33(4):411-5.
2007: William C Becker; David A Fiellin; Rani A Desai
Non-medical use, abuse and dependence on sedatives and tranquilizers among U.S. adults: psychiatric and socio-demographic correlates.
Drug and alcohol dependence 2007;90(2-3):280-7.
2007: Adam J Gordon; Lynn E Sullivan; Daniel P Alford; Julia H Arnsten; Marc N Gourevitch; Stefan G Kertesz; Hillary V Kunins; Joseph O Merrill; Jeffrey H Samet; David A Fiellin
Update in addiction medicine for the generalist.
Journal of general internal medicine 2007;22(8):1190-4.
2007: David A Fiellin
The first three years of buprenorphine in the United States: experience to date and future directions.
Journal of addiction medicine 2007;1(2):62-7.
2007: Emlyn S Jones; David A Fiellin
Women and opioid dependence treatment: office-based versus opioid treatment program-based care?
Substance abuse : official publication of the Association for Medical Education and Research in Substance Abuse 2007;28(2):3-8.
2007: Brent A Moore; David A Fiellin; Declan T Barry; Lynn E Sullivan; Marek C Chawarski; Patrick G O'Connor; Richard S Schottenfeld
Primary care office-based buprenorphine treatment: comparison of heroin and prescription opioid dependent patients.
Journal of general internal medicine 2007;22(4):527-30.
2007: Jeanette M Tetrault; Kristina Crothers; Brent A Moore; Reena Mehra; John Concato; David A Fiellin
Effects of marijuana smoking on pulmonary function and respiratory complications: a systematic review.
Archives of internal medicine 2007;167(3):221-8.
2007: Declan T Barry; Brent A Moore; Michael V Pantalon; Marek C Chawarski; Lynn E Sullivan; Patrick G O'Connor; Richard S Schottenfeld; David A Fiellin
Patient satisfaction with primary care office-based buprenorphine/naloxone treatment.
Journal of general internal medicine 2007;22(2):242-5.
2007: Bridget A Martell; Patrick G O'Connor; Robert D Kerns; William C Becker; Knashawn H Morales; Thomas R Kosten; David A Fiellin
Systematic review: opioid treatment for chronic back pain: prevalence, efficacy, and association with addiction.
Annals of internal medicine 2007;146(2):116-27.
2006: Lynn E Sullivan; R Douglas Bruce; David Haltiwanger; Gregory M Lucas; Lois Eldred; Ruth Finkelstein; David A Fiellin
Initial strategies for integrating buprenorphine into HIV care settings in the United States.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2006;43 Suppl 4():S191-6.
2006: Lynn E Sullivan; Declan Barry; Brent A Moore; Marek C Chawarski; Jeanette M Tetrault; Michael V Pantalon; Patrick G O'Connor; Richard S Schottenfeld; David A Fiellin
A trial of integrated buprenorphine/naloxone and HIV clinical care.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2006;43 Suppl 4():S184-90.
2006: David A Fiellin; Gerald Friedland; Marc N Gourevitch
Opioid dependence: rationale for and efficacy of existing and new treatments.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2006;43 Suppl 4():S173-7.
2006: William H Sledge; Karen E Brown; Jeffrey Levine; David A Fiellin; Marek C Chawarski; William D White; Patrick G O'Connor
A randomized trial of primary intensive care to reduce hospital admissions in patients with high utilization of inpatient services.
Disease management : DM 2006;9(6):328-38.
2006: Erik W Gunderson; David A Fiellin; Frances R Levin; Lynn E Sullivan; Herbert D Kleber
Evaluation of a combined online and in person training in the use of buprenorphine.
Substance abuse : official publication of the Association for Medical Education and Research in Substance Abuse 2006;27(3):39-45.
2006: Lynn E Sullivan; Jeanette M Tetrault; Deepa Bangalore; David A Fiellin
Training HIV physicians to prescribe buprenorphine for opioid dependence.
Substance abuse : official publication of the Association for Medical Education and Research in Substance Abuse 2006;27(3):13-8.
2006: David A Fiellin; Andrew Saxon; John A Renner
Mental health after deployment to Iraq or Afghanistan.
JAMA : the journal of the American Medical Association 2006;296(5):515; author reply 516.
2006: Kevin L Kraemer; Kathleen A McGinnis; Melissa Skanderson; Robert Cook; Adam Gordon; Joseph Conigliaro; Yujing Shen; David A Fiellin; Amy C Justice
Alcohol problems and health care services use in human immunodeficiency virus (HIV)-infected and HIV-uninfected veterans.
Medical care 2006;44(8 Suppl 2):S44-51.
2006: David A Fiellin; Michael V Pantalon; Marek C Chawarski; Brent A Moore; Lynn E Sullivan; Patrick G O'Connor; Richard S Schottenfeld
Counseling plus buprenorphine-naloxone maintenance therapy for opioid dependence.
The New England journal of medicine 2006;355(4):365-74.
2006: Reena Mehra; Brent A Moore; Kristina Crothers; Jeanette M Tetrault; David A Fiellin
The association between marijuana smoking and lung cancer: a systematic review.
Archives of internal medicine 2006;166(13):1359-67.
2006: David A Fiellin
Buprenorphine: effective treatment of opioid addiction starts in the office.
American family physician 2006;73(9):1513-4.
2006: David A Fiellin; Patrick G O'Connor; Yongfei Wang; Martha J Radford; Harlan Krumholz
Quality of care for acute myocardial infarction in elderly patients with alcohol-related diagnoses.
Alcoholism, clinical and experimental research 2006;30(1):70-5.
2005: Lynn E Sullivan; David A Fiellin
Buprenorphine: its role in preventing HIV transmission and improving the care of HIV-infected patients with opioid dependence.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2005;41(6):891-6.
2005: Lynn E Sullivan; Marek C Chawarski; Patrick G O'Connor; Richard S Schottenfeld; David A Fiellin
The practice of office-based buprenorphine treatment of opioid dependence: is it associated with new patients entering into treatment?
Drug and alcohol dependence 2005;79(1):113-6.
2005: Karen E Brown; Jeffrey Levine; David A Fiellin; Patrick O'Connor; William H Sledge
Primary intensive care: pilot study of a primary care-based intervention for high-utilizing patients.
Disease management : DM 2005;8(3):169-77.
2005: Lynn E Sullivan; David A Fiellin; Patrick G O'Connor
The prevalence and impact of alcohol problems in major depression: a systematic review.
The American journal of medicine 2005;118(4):330-41.
2005: William C Becker; David A Fiellin
Provider satisfaction with office-based treatment of opioid dependence: a systematic review.
Substance abuse : official publication of the Association for Medical Education and Research in Substance Abuse 2005;26(1):15-22.
2005: Gail D'Onofrio; Michael V Pantalon; Linda Degutis; David A Fiellin; Patrick G O'Connor
Development and implementation of an emergency practitioner-performed brief intervention for hazardous and harmful drinkers in the emergency department.
Academic emergency medicine : official journal of the Society for Academic Emergency Medicine 2005;12(3):249-56.
2005: Sharon K Inouye; David A Fiellin
An evidence-based guide to writing grant proposals for clinical research.
Annals of internal medicine 2005;142(4):274-82.
2005: Lynn E Sullivan; David S Metzger; Paul J Fudala; David A Fiellin
Decreasing international HIV transmission: the role of expanding access to opioid agonist therapies for injection drug users.
Addiction (Abingdon, England) 2005;100(2):150-8.
2004: Jeffrey G Wong; Eric S Holmboe; Gail B Jara; Judith Martin; William C Becker; David A Fiellin
Faculty development in small-group teaching skills associated with a training course on office-based treatment of opioid dependence.
Substance abuse : official publication of the Association for Medical Education and Research in Substance Abuse 2004;25(4):35-40.
2004: David A Fiellin; Herbert D Kleber; Jeanne G Trumble-Hejduk; A Thomas McLellan; Thomas R Kosten
Consensus statement on office-based treatment of opioid dependence using buprenorphine.
Journal of substance abuse treatment 2004;27(2):153-9.
2004: David A Fiellin
Substance use of disorders in HIV-infected patients: impact and new treatment strategies.
Topics in HIV medicine : a publication of the International AIDS Society, USA 2004;12(3):77-82.
2004: David A Fiellin; Patrick G O'Connor; Marek C Chawarski; Richard S Schottenfeld
Processes of care during a randomized trial of office-based treatment of opioid dependence in primary care.
The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions 2004;13 Suppl 1():S67-78.
2004: Thomas R Kosten; David A Fiellin
Buprenorphine for office-based practice: consensus conference overview.
The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions 2004;13 Suppl 1():S1-7.
2004: Lynn E Sullivan; David A Fiellin
Hepatitis C and HIV infections: implications for clinical care in injection drug users.
The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions 2004;13(1):1-20.
2003: Mark L Kraus; Patrick O'Connor; Thomas F Babor; Robert J Brunell; David A Fiellin; Eric S Holmboe; Thomas A Kirk; Patrick Leone
Connecticut statewide addiction medicine/psychiatry grand rounds.
Connecticut medicine 2003;67(6):357-9.
2003: David A Fiellin
Methadone syrup injection in Australia: a sentinel finding?
Addiction (Abingdon, England) 2003;98(4):385-6.
2003: David A Fiellin; Robert A Rosenheck; Thomas R Kosten
Coordination of medical care and opioid dependence treatment in primary care: a case report.
Substance abuse : official publication of the Association for Medical Education and Research in Substance Abuse 2003;24(1):43-6.
2003: David A Fiellin; Andrea G Barthwell
Guideline development for office-based pharmacotherapies for opioid dependence.
Journal of addictive diseases 2003;22(4):109-20.
2002: David A Fiellin; Patrick G O'Connor
New federal initiatives to enhance the medical treatment of opioid dependence.
Annals of internal medicine 2002;137(8):688-92.
2002: David A Fiellin; Patrick G O'Connor
Clinical practice. Office-based treatment of opioid-dependent patients.
The New England journal of medicine 2002;347(11):817-23.
2002: David A Fiellin; Richard L Brown; Richard Butler; Gail D'Onofrio; Patrick G O'Connor
The physician's role in caring for patients with substance use disorders: implications for medical education and training.
Substance abuse : official publication of the Association for Medical Education and Research in Substance Abuse 2002;23(3 Suppl):207-22.
2002: Marc N Potenza; David A Fiellin; George R Heninger; Bruce J Rounsaville; Carolyn M Mazure
Gambling: an addictive behavior with health and primary care implications.
Journal of general internal medicine 2002;17(9):721-32.
2002: David A Fiellin; Patrick G O'Connor; Eric S Holmboe; Ralph I Horwitz
Risk for delirium tremens in patients with alcohol withdrawal syndrome.
Substance abuse : official publication of the Association for Medical Education and Research in Substance Abuse 2002;23(2):83-94.
2002: David A Fiellin; Michael V Pantalon; Juliana Pakes; Patrick G O'Connor; Marek C Chawarski; Richard S Schottenfeld
Treatment of heroin dependence with buprenorphine in primary care.
The American journal of drug and alcohol abuse 2002;28(2):231-41.
2001: David A Fiellin; Patrick G O'Connor; Marek C Chawarski; Juliana Pakes; Michael V Pantalon; Richard S Schottenfeld
Methadone maintenance in primary care: a randomized controlled trial.
JAMA : the journal of the American Medical Association 2001;286(14):1724-31.
2001: Jody L Sindelar; David A Fiellin
Innovations in treatment for drug abuse: solutions to a public health problem.
Annual review of public health 2001;22():249-72.
2000: David A Fiellin; M Carrington Reid; Patrick G O'Connor
Outpatient management of patients with alcohol problems.
Annals of internal medicine 2000;133(10):815-27.
2000: E S Holmboe; David A Fiellin; E Cusanelli; M Remetz; Harlan Krumholz
Perceptions of benefit and risk of patients undergoing first-time elective percutaneous coronary revascularization.
Journal of general internal medicine 2000;15(9):632-7.
2000: David A Fiellin; M Carrington Reid; Patrick G O'Connor
Screening for alcohol problems in primary care: a systematic review.
Archives of internal medicine 2000;160(13):1977-89.
2000: Patrick G O'Connor; David A Fiellin
Pharmacologic treatment of heroin-dependent patients.
Annals of internal medicine 2000;133(1):40-54.
2000: David A Fiellin; M Carrington Reid; Patrick G O'Connor
New therapies for alcohol problems: application to primary care.
The American journal of medicine 2000;108(3):227-37.
2000: David A Fiellin; John Concato
Beyond diagnosis: patient mix and challenges to patient care in ambulatory training sites.
The American journal of the medical sciences 2000;319(2):106-10.
2000: M Carrington Reid; I M Voynick; Peter Peduzzi; David A Fiellin; Mary E Tinetti; John Concato
Alcohol exposure and health services utilization in older veterans.
Journal of clinical epidemiology 2000;53(1):87-93.
1999: M Carrington Reid; David A Fiellin; Patrick G O'Connor
Hazardous and harmful alcohol consumption in primary care.
Archives of internal medicine 1999;159(15):1681-9.